| Name | Title | Contact Details |
|---|---|---|
Sanjeeve Bala |
Vice President, US Regulatory Affairs | Profile |
Mark Dizon |
Assistant General Counsel, Chief Compliance Officer | Profile |
Mark Dizon |
Assistant General Counsel and Chief Compliance Officer | Profile |
Jamie Gillette |
Senior Director, Regulatory Affairs | Profile |
Sophia Ng |
Sr. Director and Sr. Corporate Counsel | Profile |
MicroConstants, Inc. is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Flame Biosciences is a clinical stage company focused on the research, development and commercialization of transformative therapies for cancer and other inflammatory conditions.
Neoleukin Therapeutics emerged from the University of Washington Institute for Protein Design in January of 2019. We are creating next generation immunotherapies using breakthrough de novo protein design technology. We use natural protein complexes as inspiration to develop custom designed proteins with superior pharmaceutical properties.
Carol Cole Company is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
VelosBio Inc. is a clinical-stage biopharmaceutical company committed to developing novel, first-in-class, ROR1-directed therapeutics to transform the lives of patients with cancer. Its lead candidate, VLS-101, is a ROR1-directed ADC being developed for patients with hematologic and solid tumor malignancies. The company is developing a broad pipeline of therapeutics targeting ROR1 in oncologic indications with high unmet medical need.